This inventor holds 8 USPTO granted patents and 17 published patent applications. Top assignees: Dana-Farber-Cancer Institute Inc., Hoffmann-La Roche Inc., The United States of America as Represented by the Department of Health. Active years: 1988-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Glen Ridge, NJ (US) (1995 - 1997)
- Brookline, MA (US) (1988 - 1998)
Company Filing History:
6 out of 1,269 
2 out of 5,027 
1 out of 1,217 
Years Active: 1988-1998
Title: The Innovative Contributions of Craig A. Rosen
Introduction: Craig A. Rosen, based in Brookline, MA, has made significant strides in the field of biomedical research, particularly in the realm of HIV studies. With a portfolio of 8 patents to his name, Dr. Rosen has developed groundbreaking technologies that contribute to our understanding and potential treatment of HIV.
Latest Patents: Among his latest patents, Dr. Rosen has developed a nucleic acid encoding the HIV-1 tat protein, which plays a crucial role in the virus's replication process. This patent includes the expression vectors comprising this nucleic acid and showcases innovative approaches to combat HIV infections. Another notable patent focuses on assay methods for tat cell lines, providing a framework for screening compounds that inhibit tat transactivation of the HIV LTR (Long Terminal Repeat). This method involves transfecting a cell line containing the tat gene and assessing the effects of various compounds, which is pivotal in the search for effective HIV treatments.
Career Highlights: Throughout his career, Dr. Rosen has been associated with prestigious institutions, including the Dana-Farber Cancer Institute and Hoffmann-La Roche Inc. His work in these organizations underscores his commitment to advancing medical research and developing therapeutic innovations.
Collaborations: Dr. Rosen has collaborated with prominent scientists in the field, including William A. Haseltine and Joseph G. Sodroski. These partnerships have been instrumental in fostering an environment of collaborative research, ultimately leading to significant advancements in HIV research and treatment methodologies.
Conclusion: Craig A. Rosen's contributions to the field of HIV research have been invaluable. With numerous patents and collaborations that reflect his dedication to innovation, Dr. Rosen continues to be a prominent figure in the pursuit of effective treatments for HIV. His ongoing efforts not only push the boundaries of scientific understanding but also offer hope for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile